alphastocknews.com
Kazia Therapeutics (KZIA) Stock Falls On Seemingly Positive Data | Alpha Stock News
Kazia Therapeutics Ltd (NASDAQ: KZIA) is having an overwhelmingly rough start to the trading session this morning, which may come as a surprise to many. The company issued what seemed to be positive data from a glioblastoma study, but the stock is down 18.51% early on. Nonetheless, there’s a good reason for the declines. Here’s …